全文获取类型
收费全文 | 13384篇 |
免费 | 1821篇 |
国内免费 | 328篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 328篇 |
妇产科学 | 92篇 |
基础医学 | 787篇 |
口腔科学 | 104篇 |
临床医学 | 976篇 |
内科学 | 1504篇 |
皮肤病学 | 287篇 |
神经病学 | 426篇 |
特种医学 | 1846篇 |
外国民族医学 | 9篇 |
外科学 | 712篇 |
综合类 | 1574篇 |
现状与发展 | 3篇 |
预防医学 | 1494篇 |
眼科学 | 209篇 |
药学 | 2632篇 |
32篇 | |
中国医学 | 789篇 |
肿瘤学 | 1689篇 |
出版年
2024年 | 29篇 |
2023年 | 252篇 |
2022年 | 394篇 |
2021年 | 676篇 |
2020年 | 649篇 |
2019年 | 574篇 |
2018年 | 647篇 |
2017年 | 589篇 |
2016年 | 580篇 |
2015年 | 502篇 |
2014年 | 1076篇 |
2013年 | 1136篇 |
2012年 | 876篇 |
2011年 | 933篇 |
2010年 | 721篇 |
2009年 | 611篇 |
2008年 | 643篇 |
2007年 | 577篇 |
2006年 | 485篇 |
2005年 | 387篇 |
2004年 | 334篇 |
2003年 | 333篇 |
2002年 | 269篇 |
2001年 | 243篇 |
2000年 | 206篇 |
1999年 | 192篇 |
1998年 | 145篇 |
1997年 | 138篇 |
1996年 | 115篇 |
1995年 | 118篇 |
1994年 | 99篇 |
1993年 | 96篇 |
1992年 | 72篇 |
1991年 | 81篇 |
1990年 | 75篇 |
1989年 | 90篇 |
1988年 | 61篇 |
1987年 | 56篇 |
1986年 | 58篇 |
1985年 | 83篇 |
1984年 | 64篇 |
1983年 | 36篇 |
1982年 | 47篇 |
1981年 | 40篇 |
1980年 | 34篇 |
1979年 | 39篇 |
1978年 | 10篇 |
1977年 | 23篇 |
1976年 | 15篇 |
1975年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
Despite the widespread use of botulinum toxin to treat muscle dystonias, no method exists to quantify muscle paralysis in either human or nonhuman models. In this study we examined how the location, dose, and volume of botulinum injection affects paralysis in the rat tibialis anterior muscle. Paralysis was quantified by electrically stimulating the nerve to the tibialis anterior and then staining sections of the muscle for glycogen. The areas of glycogen-containing fibers represented regions of botulinum action. The results showed that the most important injection technique is to inject botulinum directly into the motor endplate region of a muscle. Injections only 0.5 cm from the motor endplate resulted in a 50% decrease in paralysis. Increases in dose increased paralysis, however, some of that increase was simply due to the increased volume of injection. Thus, delivering toxin in small volumes near the MEP band of a muscle should produce the most effectiveparalysis. © 1993 John Wiley & Sons, Inc. 相似文献
32.
M. Wensing A. H. Penninks† S. L. Hefle‡ J. H. Akkerdaas§ R. van Ree§ S. J. Koppelman† C. A. F. M. Bruijnzeel-Koomen A. C. Knulst 《Clinical and experimental allergy》2002,32(12):1757-1762
BACKGROUND: The risk for allergic reactions depends on the sensitivity of individuals and the quantities of offending food ingested. The sensitivity varies among allergic individuals, as does the threshold dose of a food allergen capable of inducing an allergic reaction. OBJECTIVE: This study aimed at determining the distribution of minimum provoking doses of hazelnut in a hazelnut-allergic population. METHODS: Thirty-one patients with a history of hazelnut-related allergic symptoms, a positive skin prick test to hazelnut and/or an elevated specific IgE level, were included. Double-blind, placebo-controlled food challenges (DBPCFC) were performed with seven increasing doses of dried hazelnut (1 mg to 1 g hazelnut protein) randomly interspersed with seven placebo doses. RESULTS: Twenty-nine patients had a positive challenge. Itching of the oral cavity and/or lips was the first symptom in all cases. Additional gastrointestinal symptoms were reported in five patients and difficulty in swallowing in one patient. Lip swelling was observed in two patients, followed by generalized urticaria in one of these. Threshold doses for eliciting subjective reactions varied from a dose of 1 mg up to 100 mg hazelnut protein (equivalent to 6.4-640 mg hazelnut meal). Extrapolation of the dose-response curve showed that 50% of our hazelnut-allergic population will suffer from an allergic reaction after ingestion of 6 mg (95% CI, 2-11 mg) of hazelnut protein. Objective symptoms were observed in two patients after 1 and 1,000 mg, respectively. CONCLUSION: DBPCFCs demonstrated threshold doses in half of the hazelnut-allergic patients similar to doses previously described to be hidden in consumer products. This stresses the need for careful labelling and strategies to prevent and detect contamination of food products with hazelnut residues. 相似文献
33.
Prediction of steady state bioequivalence relationships using single dose data II-nonlinear kinetics
A J Jackson 《Biopharmaceutics & drug disposition》1989,10(5):489-503
Two nonlinear pharmacokinetic models were simulated to investigate the relationship between single and multiple dose bioequivalency parameters for drugs such as phenytoin and propranolol which exhibit either saturable elimination kinetics or a capacity limited first pass effect. Mean Tmax, Cmax and area under the plasma-concentration time curve values from 0 to infinity (AUC 0-infinity) were compared after a single and multiple dose(s) of a test or reference drug. The aim was to determine if there were systematic changes in the limits of the single dose confidence interval at steady state that would limit the usefulness of confidence intervals following a single dose in accurately predicting bioavailability following multiple dosing. The 90 per cent confidence interval expressed as a percentage of the reference mean for Tmax, Cmax, and AUC 0-infinity showed model dependent changes from single to multiple dosing in response to the level of data error and changes in absorption. Changes in clearance also seemed to have a marked effect on the observed limits of the single and multiple dose confidence intervals especially for Cmax which showed a characteristic change in the intervals as a function of the clearance ratio. The model used to describe phenytoin had confidence intervals for Cmax and AUC 0-infinity from single to multiple dosing that were similar to that seen for the experimental data. However, the model predictions for Tmax confidence intervals following single and multiple dosing was at variance with the experimental data for formulations A and B. 相似文献
34.
本文用磷酸盐Giemsa法观察了小剂量X射线照射对人离体外周血淋巴细胞SCE的影响。其结果照射组各剂量点均不明显地高于对照组,证实了SCE对电离辐射不敏感,说明染色体结构畸变和SCE的发生是彼此独立的两个不同事件。 相似文献
35.
Prediction of steady-state bioequivalence relationships using single dose data I-linear kinetics 总被引:1,自引:0,他引:1
A J Jackson 《Biopharmaceutics & drug disposition》1987,8(5):483-496
Simulated data using a linear one- and two-compartment body model with different absorption characteristics were used to evaluate the ability of single dose bioavailability data to predict the relationships that exist at steady state. This was done by comparing the confidence intervals obtained from single and multiple dose data sets for the parameters of Tmax, Cmax, and area under the curve from time zero to infinity (AUC0-infinity). As a consequence of Tmax and Cmax decreasing and increasing from single to multiple dosing regimens, the confidence intervals for these parameters reflected these changes. The 90 per cent confidence interval expressed as a percentage of the reference mean increased or decreased for Tmax dependent upon the ratio of Ka test/Ka reference, and decreased for Cmax while the interval for AUC0-infinity exhibited no predictable pattern and appeared to be influenced by the amount of error in the data set. Alteration of either the dosing interval or the fraction absorbed did not affect the pattern of change in the confidence intervals for Tmax and Cmax, but the latter did result in a decrease in the interval for AUC0-infinity. Analysis of the confidence intervals for Tmax, Cmax and AUC0-infinity in bioequivalency studies for quinidine gluconate and procainamide hydrochloride following administration of single and multiple doses to different subjects appeared to be consistent with the patterns observed for the simulated data sets. 相似文献
36.
37.
An extensive field survey allowed us to expand the geographical distribution of the scorpion Tityus perijanensis in the Perijá range, western Zulia State, Venezuela, including areas where adult cases of severe scorpionism have been reported. 16S ribosomal RNA (rRNA) gene sequencing, DL(50) determination, and native PAGE suggest low genetic and venom proteomic divergence across the distribution range. The results also indicate phylogenetic divergence between T. perijanensis and T. discrepans, the species prevalent in northcentral Venezuela. T. perijanensis venom lethality (0.91-0.94 mg/kg) is comparable to that of the Brazilian T. serrulatus and ranks highest among toxic Venezuelan Tityus studied so far. The data indicate that the Perijá range should be included amongst the endemic areas of scorpionism of Venezuela and Colombia. 相似文献
38.
本文提出的“差式氧化数法”特别适用于有机化学反应方程式的平衡。在未平衡方程式之前即可直接求出有机物的氧化还原当量,然后再平衡方程式。较以前先平衡方程式,再间接计算氧化还原当量的方法简便,快速,易掌握。 相似文献
39.
酸枣仁提取物急性毒性实验研究 总被引:1,自引:0,他引:1
目的 观察酸枣仁醇提取物的急性毒性反应.方法 ①小鼠尾静脉注射不同剂量的酸枣仁醇提取物,连续观察14 d,记录小鼠的急性毒性反应,并计算LD50及LD50 95%可信限;②小鼠灌胃给药,测定一次给予酸枣仁醇提取物的安全剂量.结果 ①静脉注射酸枣仁醇提取物后,部分小鼠出现中毒反应并死亡,测得LD50为27.5 g·kg-1,LD50 95%可信限为25.1~30.1 g·kg-1,死亡动物尸检,其主要脏器未见病理改变.14 d后存活小鼠体重平均增加20.4%,略高于生理盐水组(18.2%).②小鼠灌胃给药(340 g·kg-1,相当于成人一次用量的326倍)后,连续观察14 d,小鼠全部存活,无明显毒性反应,小鼠体重平均增长17.2%.结论 酸枣仁醇提取物毒性很低,临床给药安全可靠. 相似文献
40.
目的 探讨低剂量辐射全身照射对小鼠Lewis肺癌移植肿瘤基因-放疗方案中的免疫增强作用机制。方法 小鼠右后肢皮下接种Lewis肺癌细胞建立荷瘤模型,基因-放疗组中小鼠肿瘤局部注射由多聚乙烯亚胺包裹的pEgr-IL18-B7.1重组质粒,分别接受由2 Gy 局部照射和0.075 Gy 全身照射组合的不同治疗方案,通过3H-TdR标记方法检测小鼠CTL和NK细胞毒活性,ELISA方法检测TNF-α和IFN-γ分泌活性,观察各治疗组对荷瘤小鼠抗肿瘤免疫的作用。结果 在pEgr-IL18-B7.1基因治疗方案中,单次大剂量辐射局部照射后加多次低剂量全身照射与常规多次大剂量辐射局部照射相比,小鼠CTL和NK细胞毒活性显著增强,TNF-α和IFN-γ分泌活性有不同程度的增高。 结论 低剂量辐射可以通过促进CTL和NK细胞毒效应,上调TNF-α和IFN-γ细胞因子表达,从而增强机体抗肿瘤免疫功能,提高肿瘤基因-放疗的抑瘤效果。 相似文献